Abstract:Abstract Objective: To study the effect and protection mechanism of sea buckthorn sterol on acute liver injury induced by carbon tetrachloride (CCl 4 ) in rats. Methods: CCl 4 was used to make a rat model of acute liver injury. The rats were divided into six groups including blank control group, model control group, bifendate treated positive control group, low-, medium-, and high-doses of sea buckthorn sterol treated groups. The enzyme activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), gamma-glutamyl transpeptidase (γ-GT), and catalase (CAT) were investigated. Total antioxidant capacity (T-AOC), total protein (TP), and the content of malondialdehyde (MDA), the level of cyclooxygenase-2 (COX-2) and prostaglandin E 2 (PGE 2 ) in liver tissues were determined. HE staining was used for the observation of inflammatory changes of liver tissues. The endoplasmic reticulum and mitochondria in liver tissues were observed by electron microscope. Wide range of targeted technologies were used for the detection of the full-spectrum metabolome, and metabolome differences among samples were investigated by means of the combination of UPLC-MS/MS detection platform, self-built database, and multivariate statistical analysis. Transcriptomics were studied using the RNA-SEQ method. Based on comparison results, gene expression levels were analyzed, and differentially expressed genes were identified according to their expression levels in different samples. Results: After the treatment of sea buckthorn sterol, the activities of SOD, GSH-Px, CAT, T-AOC, and TP in liver tissues were increased, while the activities of γ-GT, COX-2, and PGE 2 were decreased, and the content of MDA was also reduced. Sea buckthorn sterol can reduce the inflammatory lesions in liver tissues, and the damage of the structure of endoplasmic reticulum and mitochondria of liver cells were significantly alleviated compared with the model group. The levels of L-malic acid, 7Z, 10Z, 13Z, 16Z, 19Z-docosapentaenoic acid, creatine, N-acetyl-l-alanine, N-acetyl-aspartic acid, trigonelline, 4-guanidine butyric acid, N-amidine L-aspartic acid, CE(16:1), CE(18:2), PE(16:1/16:0), DG(16:0/18:02/0:0), TG(14:0/18:0/20:4), TG(16:0/18:0/20:4), TG(16:0/16:1/22:5), N-glycine-l-leucine, and FFA(6:0) were significantly restored after the treatment of sea buckthorn sterol. Sea buckthorn sterol could participate in the citric acid cycle, arginine and proline metabolism, alanine, aspartate and glutamate metabolism, niacin and niacinamide metabolism, fat digestion and absorption, and glycerophospholipid metabolism. Besides, the expressions of Cyp1a1, Noct, and Tubb6 could be regulated by sea buckthorn sterol, and thus the metabolic damage by CCl 4 was reduced. Conclusion: Sea buckthorn sterol could improve liver function in the animal model of CCl 4 -induced acute liver injury in rats. The mechanism of liver protection is likely related to the regulation of metabolic disorders, anti-lipid peroxidation, and inhibition of inflammatory response.

Recombinant T-cell receptors: an immunologic link to cancer therapy.

Liubao Tea Extract Restrains Obesity-Related Hyperlipidemia Via Regulation of AMPK/p38/NF-κB Pathway and Intestinal Microbiota

Network pharmacology analysis and experimental validation to explore the mechanism of sea buckthorn flavonoids on hyperlipidemia

Combining bioinformatics and multiomics strategies to investigate the key microbiota and active components of Liupao tea ameliorating hyperlipidemia

Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota

Study on Preventive Effect of Tea Plant Flower on Obesity and Hyperlipidemia of Rats

Exploring the effect and mechanism of Hippophae rhamnoides L. triterpenoid acids on improving NAFLD based on network pharmacology and experimental validation in vivo and in vitro

Research progress of sea buckthorn (Hippophae rhamnoides L.) in prevention and treatment of cardiovascular disease

Anti-hyperlipidemia effect of sea buckthorn fruit oil extract through the AMPK and Akt signaling pathway in hamsters

Effects of cholesterol-lowering probiotic fermentation on the active components and in vitro hypolipidemic activity of sea buckthorn juice

A UPLC-Q-TOF/MS and network pharmacology method to explore the mechanism of Anhua fuzhuan tea intervention in nonalcoholic fatty liver disease

Relationship of GTP-binding proteins, phospholipase C, and PGE2 synthesis in rat glomerular mesangial cells.

Metabonomic Profiling in Study Protective Effect of Sea Buckthorn Sterol on Acute Liver Injury Induced By Carbon Tetrachloride in Rats

Dietary Supplementation with Sea Buckthorn Berry Puree Alters Plasma Metabolomic Profile and Gut Microbiota Composition in Hypercholesterolemia Population

Asymmetric γ-Allylation of α,β-Unsaturated Aldehydes by Combined Organocatalysis and Transition-Metal Catalysis.

Effects of sea buckthorn puree on risk factors of cardiovascular disease in hypercholesterolemia population: a double-blind, randomized, placebo-controlled trial

Hypolipidemic Effects and Mechaniasm of Tea Plant New Strain Camellia sinensis CV.CFT-1 Extract

Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats

Microbial Fermentation Enhances the Effect of Black Tea on Hyperlipidemia by Mediating Bile Acid Metabolism and Remodeling Intestinal Microbes

TFEB activator tanshinone IIA and derivatives derived from Salvia miltiorrhiza Bge. Attenuate hepatic steatosis and insulin resistance

Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions <or=40%, 41% to 49%, and >or=50% having percutaneous coronary revascularization.